Zacks.com on MSN23h
Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today
Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $502.92, signifying a +1.51% move from its prior day's close.
3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
Many investors view the healthcare sector as a safe haven when the stock market is turbulent. Here are three no-brainer ...
Best Biotech Stocks To Watch Now – March 12th
AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...
Investing Snacks20h
Vertex Pharma Gets Upgrade as Analysts Boost Price Target
Vertex Pharmaceuticals received an upgrade from StockNews.com, moving from a “hold” to a “buy” rating. Other analysts have ...
Coeptis Inc. (COEP) Expands Cancer Immunotherapy Portfolio with Exclusive GEAR Cell Therapy License
Coeptis Inc. (Nasdaq: COEP) has taken a bold step forward in the fight against cancer by securing exclusive worldwide ...
CRISPR Therapeutics: An Uninspiring Start For Casgevy
CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious ...
US close: Dow Jones extends losing streak to fourth session
Major indices closed lower on Thursday as market participants digested yet another key inflation reading and new tariff ...
Investor's Business Daily on MSN1d
Dow Jones Tumbles 537 Points On Trump Tariff Threats; S&P 500 Enters Correction
The Dow Jones Industrial Average tumbled 537 points Thursday as Wall Street reacted to tariff threats from President Trump.